Stock A000020 DONGWHA PHARM.CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Dongwha Pharm.Co.,Ltd

Equities

A000020

KR7000020008

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
8,750 KRW +0.57% Intraday chart for Dongwha Pharm.Co.,Ltd +0.57% -14.80%
2023 Cong Ty Co Phan Tscare announced that it has received KRW 37.442505601 billion in funding from Dongwha Pharm.Co.,Ltd CI
2023 Oncocross Co., Ltd. announced that it has received KRW 15.00002592 billion in funding from InterVest Co., Ltd., Dongwha Pharm.Co.,Ltd and other investors CI

Business Summary

DONGWHA PHARM.CO., LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. It also provides medicine raw materials, health food and drinks, as well as cosmetics. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 810

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
92.8 %
315,928 92.8 % 335,135 92.8 % +6.08%
Medical Equipment
7.4 %
24,614 7.2 % 26,561 7.4 % +7.91%
Consolidated Adjustment
-0.2 %
-116 0.0 % -587 -0.2 % +406.78%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
95.0 %
321,926 94.6 % 342,936 95.0 % +6.53%
Overseas
5.0 %
18,501 5.4 % 18,173 5.0 % -1.77%

Managers

Managers TitleAgeSince
Jun-Ha Yoo CEO
 Chief Executive Officer 60 -
Ma-Se Lee CTO
 Chief Tech/Sci/R&D Officer 61 -
Dae-Hyun Kim BRD
 Director/Board Member 47 -
In-Ho Yoon BRD
 Director/Board Member 40 -
Hyun-Gyeong Yoon PRN
 Corporate Officer/Principal 44 -
Do-Joon Yoon PRN
 Corporate Officer/Principal 72 -
Gil-Joon Yoon PRN
 Corporate Officer/Principal 67 -

Members of the board

Members of the board TitleAgeSince
Do-Joon Yoon PRN
 Corporate Officer/Principal 72 -
In-Ho Yoon BRD
 Director/Board Member 40 -
Sem-An Oh BRD
 Director/Board Member 68 19-03-20
Jun-Ha Yoo CEO
 Chief Executive Officer 60 -
Gwang-Jun Kim BRD
 Director/Board Member 47 20-03-18
Na-Na Geum BRD
 Director/Board Member 41 20-03-18
Dae-Hyun Kim BRD
 Director/Board Member 47 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,931,470 17,249,808 ( 61.76 %) 213,540 ( 0.7645 %) 61.76 %

Shareholders

NameEquities%Valuation
In-Ho Yoon
17.46 %
4,877,160 17.46 % 34 M ₩
Gasong Foundation
6.392 %
1,785,425 6.392 % 12 M ₩
Do-Joon Yoon
5.131 %
1,433,085 5.131 % 10 M ₩
Dong Wha Pharm Co., Ltd. Employee Stock Ownership Association
3.208 %
896,120 3.208 % 6 M ₩
Gil-Joon Yoon
1.894 %
529,085 1.894 % 4 M ₩
DONGWHA PHARM.CO.,LTD
0.9034 %
252,340 0.9034 % 2 M ₩
Dong Wha Development Co., Ltd.
0.7727 %
215,840 0.7727 % 2 M ₩
Sun-joon Yoon
0.6096 %
170,275 0.6096 % 1 M ₩
Jin-sun Kim
0.5177 %
144,595 0.5177 % 1 M ₩
Hyun-ho Yoon
0.3158 %
88,218 0.3158 % 615 970 ₩

Holdings

NameEquities%Valuation
WHAN IN PHARM CO.,LTD.
1.88%
 350,000 1.88% 3,780,130 $
DONGWHA PHARM.CO.,LTD
0.90%
 252,340 0.90% 1,761,929 $
JETEMA, CO., LTD.
0.62%
 110,000 0.62% 1,133,296 $
GENEXINE, INC.
0.22%
 90,013 0.22% 581,700 $

Company contact information

DONG WHA PHARM Co., Ltd.

6-8/F, FastFive Tower 24 Namdaemun-ro 9-gil

04522, Seoul

+

http://www.dong-wha.co.kr
address Dongwha Pharm.Co.,Ltd(A000020)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
DONGWHA PHARM.CO.,LTD Stock Dongwha Pharm.Co.,Ltd
-14.80% 176M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.27% 43.75B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+27.47% 22.06B
SANDOZ GROUP AG Stock Sandoz Group AG
+15.08% 14.46B
CIPLA LIMITED Stock Cipla Limited
+12.33% 13.62B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.36% 11.61B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.54% 6.9B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+9.64% 5.32B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A000020 Stock
  4. Company Dongwha Pharm.Co.,Ltd